Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $1.1B |
| Sales growthchange from the year before | +41.0% |
| Gross marginshare of sales left after the direct cost of what it sells | 82.4% |
| Operating marginshare of sales left after running the business | -122.2% |
| Net marginshare of sales kept as profit | -118.4% |
| Free-cash-flow marginspare cash generated per $100 of sales | 23.3% |
| Return on invested capitalprofit made on each $100 put into the business | -67.5% |
| Return on equityprofit vs. shareholders' accounting value | -82.8% |
| Change in share countnegative = the company is buying back its shares | +72.3% |
4 insiders sold $16.6M (all under pre-arranged plans) on the open market.
| Herb TylerChief Accounting Officer | Sold (plan)Aug 3 | 1,536 shat $26.00 · $40K |
| Melwani PraveerCFO and Treasurer | Sold (plan)Jul 29 | 381,288 shat $25.13 · $9.6M |
| Rasmussen KrisChief Technology Officer | Sold (plan)Jul 29 | 261,301 shat $25.07 · $6.6M |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy